Join us for UPC, Unitary Patent and Brexit discussions in Munich and Paris

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Join us for UPC, Unitary Patent and Brexit discussions in Munich and Paris

UPC

Managing IP's next events are our European Patent Forums, being held in Munich on September 6 and Paris on September 8

munich-skyline2.jpg

The agendas for both days have been updated and can be seen online (Munich and Paris).

Notably, each day will open with a session on the patent implications of Brexit. We are delighted that Margot Fröhlinger of the EPO will be speaking at this.

Having talked to her at the recent CIPA Anniversary Dinner, I know Fröhlinger has lots of interesting thoughts about what might happen to the UPC and Unitary Patent after the UK vote to leave the EU, including how the plans might be revised to ensure the system remains useful to patent owners and applicants. So this is a session not to be missed!

There will also be other panels looking at aspects of the UPC, including a US perspective, and sessions on litigation strategy in Europe more generally.

paris-skyline2.jpg

Other topics on the agenda include SEPs and FRAND, evidence and ADR, and there will be dedicated sessions on life sciences/pharma and IT/TMT.

This is the fourth year we have held the European Patent Reform Forum, and arguably there is more to discuss now than ever before. 

I know previous attendees have valued the presentations and discussions at the events so I look forward to seeing many readers there this year.

The Munich Forum is at the Charles Hotel on September 6 and the Paris Forum at the Pullman Eiffel Tower on September 8.

Find out more on our events page or download the Munich or Paris brochures (PDF).

Registration is free for in-house IP and patent counsel, R&D professionals and academics and €1,095 for advisers, consultants and private practitioners.

We have many more events coming up later this year in Europe, the US and Asia so we hope to see you at one of them before long.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article